Purpose of the company: The purchase, sale, marketing, and manufacture of pharmaceuticals (particularly therapeutic preparations for patients with kidney failure), as well as the acquisition and licensing of medicines, dietary supplements, active pharmaceutical ingredients, and fine chemicals; holding of pharmaceutical approvals; the acquisition and management of investments in other companies of the same or...
Date of articles of association: 30.6.2006
Age of the company: 19,09 years
Adress: Else-Kröner-Str. 1 61352 Bad Homburg Deutschland
Local court: 61352 Bad Homburg v.d.H.
Register number: HRB10311
The average total assets of company Fresenius Medical Care Nephrologica Deutschland GmbH over the last 5 years is 35.198.395,52 €.
The company Fresenius Medical Care Nephrologica Deutschland GmbH as of the reporting date 2022 a bank balance of approx. 103.152,96 €. That is -98,76 % less than the average bank balance in the industry of companies with this total assets.
The equity ratio of Fresenius Medical Care Nephrologica Deutschland GmbH is 0,00 % in the year 2022. In total, that ist 0,00 €.
The average number of employees of the company Fresenius Medical Care Nephrologica Deutschland GmbH for the years 2016 - 2018, 2021 - 2022 is 7.
The average absolute change in liquidity of the company Fresenius Medical Care Nephrologica Deutschland GmbH compared to the previous year amounts to 36,19 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company Fresenius Medical Care Nephrologica Deutschland GmbH amounts to 144,75 € in the year 2022.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.